MIS12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.068600E-01
Normal-vs-Stage2
3.454000E-01
Normal-vs-Stage3
2.245400E-01
Normal-vs-Stage4
3.186400E-01
Stage1-vs-Stage2
3.046000E-01
Stage1-vs-Stage3
1.151160E-01
Stage1-vs-Stage4
6.131800E-01
Stage2-vs-Stage3
1.300610E-01
Stage2-vs-Stage4
5.542400E-01
Stage3-vs-Stage4
8.700000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.694000E-01
Normal-vs-AfricanAmerican
5.229200E-01
Normal-vs-Asian
2.705000E-01
Caucasian-vs-AfricanAmerican
2.577800E-01
Caucasian-vs-Asian
1.180010E-01
AfricanAmerican-vs-Asian
1.446400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.511600E-01
Normal-vs-Female
3.886200E-01
Male-vs-Female
3.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.898800E-01
Normal-vs-Age(41-60Yrs)
4.579200E-01
Normal-vs-Age(61-80Yrs)
3.259600E-01
Normal-vs-Age(81-100Yrs)
3.504400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.768200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.512400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.899200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.997280E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.814240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.981000E-01
Normal-vs-Daily Drinker
2.899400E-01
Normal-vs-Weekly Drinker
5.943900E-02
Normal-vs-Occasional Drinker
8.308300E-02
Normal-vs-Social Drinker
1.867050E-01
Non Drinker-vs-Daily Drinker
8.325400E-01
Non Drinker-vs-Weekly Drinker
5.377600E-01
Non Drinker-vs-Occasional Drinker
1.404580E-01
Non Drinker-vs-Social Drinker
3.394200E-02
Daily Drinker-vs-Weekly Drinker
4.909400E-01
Daily Drinker-vs-Occasional Drinker
1.496440E-01
Daily Drinker-vs-Social Drinker
4.710200E-02
Weekly Drinker-vs-Occasional Drinker
5.429800E-01
Weekly Drinker-vs-Social Drinker
2.571200E-01
Occasional Drinker-vs-Social Drinker
5.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.197600E-01
Normal-vs-Grade 2
9.102600E-01
Normal-vs-Grade 3
9.124000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.707530E-02
Grade 1-vs-Grade 3
2.584200E-02
Grade 1-vs-Grade 4
9.197600E-01
Grade 2-vs-Grade 3
9.598000E-01
Grade 2-vs-Grade 4
9.102600E-01
Grade 3-vs-Grade 4
9.124000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.031800E-01
Normal-vs-NonDiabetic
3.608600E-01
Diabetic-vs-NonDiabetic
1.411830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.042400E-01
Normal-vs-NoPancreatitis
3.487400E-01
Pancreatitis-vs-NoPancreatitis
4.368600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.918000E-01
Normal-vs-N1
3.495600E-01
N0-vs-N1
3.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.866000E-01
Normal-vs-TP53-NonMutant
5.256400E-01
TP53-Mutant-vs-TP53-NonMutant
3.64820000000599E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
